U.S. Digital Therapeutics Market- Opportunity Analysis and Industry Analysis : to Surpass USD 5.08 Billion by 2027

Allied Market Research published a report, titled, "U.S. Digital Therapeutics Market by Application (Diabetes, Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS) Disease, Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder (GID), and Others), Product (Software and Device), and Sales Channel (Business-to-Business(B2B), Business-to-Consumer (B2C)): Opportunity Analysis and Industry Forecast, 2020-2027."

According to the report, the U.S. digital therapeutics industry generated $1.16 billion in 2019, and is estimated to generate $5.08 billion by 2027, growing at a CAGR of 19.2% from 2020 to 2027.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭- https://www.alliedmarketresearch.com/request-sample/7066

𝐃𝐫𝐢𝐯𝐞𝐫𝐬, 𝐫𝐞𝐬𝐭𝐫𝐚𝐢𝐧𝐭𝐬, 𝐚𝐧𝐝 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬
The U.S. digital therapeutics market is experiencing growth propelled by increased usage of tablets, smartphones, and smart wearables, coupled with the widespread adoption of healthcare apps. The rising demand to mitigate healthcare costs and the acceptance of technologically advanced healthcare products and applications further contribute to this upward trend. Nevertheless, challenges such as data privacy apprehensions and inadequate reimbursement policies act as impediments to market expansion. Conversely, the presence of supportive laws and regulations for digital health technologies, along with a surge in investments from market players, presents promising opportunities for future growth.

𝐂𝐎𝐕𝐈𝐃-19 𝐒𝐜𝐞𝐧𝐚𝐫𝐢𝐨
The Covid-19 pandemic has heightened awareness of digital health, driven by the desire to minimize infection risks through reduced physical clinic visits and an increased prevalence of mental health issues.
Digital therapeutics, championed by both startups and established industry players, are now addressing conditions like Type 2 diabetes, addiction, autism, and musculoskeletal injuries through methods such as video consultations, the release of instructional videos and blogs on their websites, and the dissemination of healthcare programs via apps.
With remote receipt of medications and treatments, individuals are increasingly turning to online channels to order necessary medications and medical devices.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐄𝐧𝐪𝐮𝐢𝐫𝐲 𝐚𝐭: https://www.alliedmarketresearch.com/purchase-enquiry/7066

𝐓𝐡𝐞 𝐬𝐨𝐟𝐭𝐰𝐚𝐫𝐞 𝐬𝐞𝐠𝐦𝐞𝐧𝐭 𝐭𝐨 𝐦𝐚𝐢𝐧𝐭𝐚𝐢𝐧 𝐢𝐭𝐬 𝐝𝐨𝐦𝐢𝐧𝐚𝐧𝐜𝐞 𝐛𝐲 2027
In 2019, the software segment played a pivotal role, constituting over two-thirds of the U.S. digital therapeutics market. It is projected to sustain its dominance in revenue share through 2027, with an anticipated highest Compound Annual Growth Rate (CAGR) of 20.3% during the forecast period. This remarkable growth is driven by the growing demand for cost-effective healthcare solutions and the presence of innovative software and apps with advanced features designed to assist individuals in maintaining good health and accessing appropriate treatment. The study also delves into the analysis of the devices segment.

𝐓𝐡𝐞 𝐛𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐭𝐨 𝐛𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭 𝐭𝐨 𝐜𝐨𝐧𝐭𝐢𝐧𝐮𝐞 𝐢𝐭𝐬 𝐡𝐢𝐠𝐡𝐞𝐬𝐭 𝐜𝐨𝐧𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐛𝐲 2027
In 2019, the business-to-business segment played a significant role, accounting for nearly two-thirds of the U.S. digital therapeutics market, and this dominance is expected to persist throughout the forecast period. The sustained contribution can be attributed to the increasing number of industry players offering favorable reimbursement policies to employees through their employers in the U.S. On the other hand, the business-to-consumer segment is anticipated to exhibit the highest Compound Annual Growth Rate (CAGR) of 19.8% from 2020 to 2027. This growth is driven by the ease of accessibility and availability of software and smart devices, coupled with a rising demand for digital therapeutic products among both patients and caregivers.

𝐓𝐡𝐞 𝐝𝐢𝐚𝐛𝐞𝐭𝐞𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭 𝐭𝐨 𝐦𝐚𝐢𝐧𝐭𝐚𝐢𝐧 𝐢𝐭𝐬 𝐝𝐨𝐦𝐢𝐧𝐚𝐧𝐭 𝐩𝐨𝐬𝐢𝐭𝐢𝐨𝐧 𝐭𝐡𝐫𝐨𝐮𝐠𝐡𝐨𝐮𝐭 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝
In 2019, the diabetes segment emerged as the leading application, capturing over one-fourth of the U.S. digital therapeutics market, and it is anticipated to sustain this dominant position in the forecast period. This prevalence is linked to the widespread occurrence of diabetes and the availability of cost-effective treatment alternatives. Conversely, the obesity segment is poised to experience the most rapid Compound Annual Growth Rate (CAGR) of 22.1% from 2020 to 2027. This growth is driven by the increasing number of overweight individuals and the convenient accessibility of digital therapeutics software applications aimed at assisting patients in maintaining proper diets and monitoring physical activities.

𝐋𝐞𝐚𝐝𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 𝐩𝐥𝐚𝐲𝐞𝐫𝐬
2MORROW, Inc.
Fitbit, Inc. (Twine Health, Inc.)
Livongo Health, Inc.
Medtronic Plc.
Omada Health, Inc.
Pear Therapeutics, Inc.
Proteus Digital Health, Inc.
Resmed, Inc. (Propeller Health)
Voluntis, Inc.
Welldoc, Inc.

𝐎𝐮𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧 𝐏𝐫𝐨𝐯𝐢𝐝𝐞𝐬 𝐘𝐨𝐮 𝐀𝐧𝐬𝐰𝐞𝐫 𝐭𝐨 𝐁𝐞𝐥𝐨𝐰 𝐌𝐞𝐧𝐭𝐢𝐨𝐧𝐞𝐝 𝐐𝐮𝐞𝐬𝐭𝐢𝐨𝐧:
Which are the driving factors responsible for the growth of market?
Which are the roadblock factors of this market?
What are the new opportunities, by which market will grow in coming years?
What are the trends of this market?
Which are main factors responsible for new product launch?
How big is the global & regional market in terms of revenue, sales and production?
How far will the market grow in forecast period in terms of revenue, sales and production?
Which region is dominating the global market and what are the market shares of each region in the overall market in 2019?
How will each segment grow over the forecast period and how much revenue will these segments account for in 2027?
Which region has more opportunities?

𝐊𝐧𝐨𝐰 𝐌𝐨𝐫𝐞 https://www.alliedmarketresearch.com/us-digital-therapeutics-market-A06701

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐢𝐧 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐃𝐨𝐦𝐚𝐢𝐧
𝐃𝐲𝐬𝐩𝐡𝐚𝐠𝐢𝐚 𝐒𝐮𝐩𝐩𝐥𝐞𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/dysphagia-supplement-market-A109152

𝐆𝐥𝐨𝐯𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/gloves-market-A08867

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com

Alied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.